Subjects: DOENÇAS VASCULARES, RETINA, RECEPTORES CELULARES, PROLIFERAÇÃO CELULAR, CITOCINAS, METABOLISMO CELULAR
ABNT
MATSUDA, Monique et al. Effects of aflibercept and bevacizumab on cell viability, cell metabolism and inflammation in hypoxic human Müller cells. PLOS ONE, v. 19, n. 3, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76972. Acesso em: 13 jan. 2025.APA
Matsuda, M., Silva, R. A. da, Roda, V. M. de P., Marquezini, M. V., Monteiro, M. L. R., & Hamassaki, D. E. (2024). Effects of aflibercept and bevacizumab on cell viability, cell metabolism and inflammation in hypoxic human Müller cells. PLOS ONE, 19( 3). doi:10.1371/journal.pone.0300370NLM
Matsuda M, Silva RA da, Roda VM de P, Marquezini MV, Monteiro MLR, Hamassaki DE. Effects of aflibercept and bevacizumab on cell viability, cell metabolism and inflammation in hypoxic human Müller cells [Internet]. PLOS ONE. 2024 ; 19( 3):[citado 2025 jan. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76972Vancouver
Matsuda M, Silva RA da, Roda VM de P, Marquezini MV, Monteiro MLR, Hamassaki DE. Effects of aflibercept and bevacizumab on cell viability, cell metabolism and inflammation in hypoxic human Müller cells [Internet]. PLOS ONE. 2024 ; 19( 3):[citado 2025 jan. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76972